Summary & Overview
HCPCS C1733: Electrophysiology Diagnostic/Ablation Catheter, Non-3D/Non-Cool-Tip
HCPCS Level II code C1733 identifies an electrophysiology catheter used for diagnostic or ablation procedures, excluding 3D or vector mapping systems and excluding cool-tip devices. This code is used when the billed item is the specific catheter device supplied for intracardiac mapping or ablation during electrophysiology studies and catheter-based arrhythmia interventions. Nationally, device supply codes such as C1733 matter because they affect facility charge capture, device inventory management, and reimbursement for high-cost cardiac procedural supplies.
Key payers included in the coverage analysis are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the clinical context for the device, typical sites of service, and which payers are commonly involved in coverage decisions. The publication also presents benchmarks where available, highlights common billing modifiers used with device supply lines, and summarizes policy considerations that influence reimbursement for electrophysiology catheters. Data not available in the input will be noted as such in relevant sections.
Billing Code Overview
HCPCS Level II code C1733 describes a catheter used in electrophysiology procedures for diagnostic or ablation purposes, specified as other than 3D or vector mapping and other than cool-tip devices. The device is intended for intracardiac mapping and ablation maneuvers during electrophysiology studies and catheter-based arrhythmia interventions.
Service type: Electrophysiology diagnostic or ablation catheter device supply
Typical site of service: Hospital inpatient or outpatient cardiac catheterization/electrophysiology lab
Clinical & Coding Specifications
Clinical Context
A 62-year-old patient with symptomatic paroxysmal supraventricular tachycardia (SVT) and recurrent palpitations is referred to the cardiac electrophysiology laboratory for an invasive electrophysiology study with possible catheter ablation. The patient arrives fasting to an outpatient procedural suite or hospital cardiac catheterization lab. Pre-procedure evaluation includes medication reconciliation (holding certain antiarrhythmics), informed consent, vascular access planning (typically femoral venous access), and surface and intracardiac mapping setup. Under conscious sedation or general anesthesia depending on patient comorbidity and physician preference, vascular access is obtained and diagnostic/ablation catheters are advanced to the right atrium, His bundle region, coronary sinus, and, if indicated, across the interatrial septum to the left atrium.
Sterile technique and fluoroscopic, electrogram, and possibly intracardiac echo guidance are used. The electrophysiology diagnostic catheter described by C1733 (a non–3D/vector mapping, non–cool-tip diagnostic/ablation catheter) is used to record intracardiac signals and deliver focal radiofrequency energy if a target arrhythmogenic focus is identified. The procedure may include programmed electrical stimulation, mapping, and limited focal ablation without use of 3D mapping systems or open irrigated (cool-tip) catheters. Post-procedure monitoring occurs in a recovery unit with rhythm observation and vascular site checks prior to discharge the same day or after an overnight observation when indicated.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|